The site will be unavailable from 11:00 PM GMT on Tuesday, 21 July 2026, until 4:00 AM GMT on Wednesday, 22 July 2026, due to scheduled maintenance.

Interventional

20th Jun 2025

Plain language summary: how aficamten performed in the SEQUOIA-HCM trial for patients with symptomatic obstructive hypertrophic cardiomyopathy

20th May 2025

Interventional

Plain language summary: how aficamten performed in the SEQUOIA-HCM trial for patients with symptomatic obstructive hypertrophic cardiomyopathy

Treatment with vutrisiran in people with transthyretin amyloidosis with cardiomyopathy: a plain language summary